ArticleBreast cancer (Tokyo, Japan)2025

Reply to the letter to the editor "Pembrolizumab added to neoadjuvant chemotherapy may improve pathological complete response in androgen-receptor positive and low tumor-infiltrating lymphocytes triple-negative breast cancer patients".

Takeshi Ushigusa et al.PubMed ↗Publisher ↗

No numbers read from the abstract.